These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Resveratrol modulates fibrillogenesis in a poly‑l‑lysine peptide.
    Author: Cieślik-Boczula K, Trombik P.
    Journal: Int J Biol Macromol; 2019 Mar 15; 125():630-641. PubMed ID: 30552924.
    Abstract:
    Resveratrol (Res) is an effective inhibitor of amyloid fibril formation and reduces neuron cell toxicity. The effect of Res on the fibrillogenesis of a polar polypeptide, poly‑l‑lysine (PLL), was studied by Fourier-transform infrared spectroscopy, vibrational circular dichroism and transmission electron microscopy. Res molecules exhibited strong and specific inhibition of β-sheet-rich fibrils formed by PLL. Side chain-side chain hydrophobic interactions of Lys side chains in aggregated β-sheet structures of PLL stabilize this aggregated state, and this interaction is targeted by Res via hydrophobic interactions. The effect of Res on PLL and other previously reported proteins/peptides sequences with fewer polar amino acids reveals that Res shows rather low sequence specificity. Instead, Res targets sequences that support strong hydrophobic interactions. The fibril-inhibition activity of Res, which is specific toward β-sheet-rich fibrils of proteins/peptides and rather non-specific to the amino acid sequence, indicates that Res is a very promising drug candidate for effective treatment of amyloid-related diseases.
    [Abstract] [Full Text] [Related] [New Search]